NEUROINFLAMMATION
Entity Detail — Knowledge Graph Node
Understanding Entity Pages
This page aggregates everything SciDEX knows about NEUROINFLAMMATION: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
Summary
NEUROINFLAMMATION is a phenotype associated with neurodegeneration research. Key relationships include: activates, regulates, associated with. Associated with AD, ALS, ALZHEIMER. Connected to 2614 entities in the SciDEX knowledge graph.
AI-generated illustration
Regenerate portrait ↻Wiki Pages (1)
Knowledge base pages for this entity
Pathway Diagram
graph TD
subgraph Signaling["Signaling"]
NEUROINFLAMMATION["NEUROINFLAMMATION"] -->|"activates"| NEURODEGENERATION["NEURODEGENERATION"]
NEUROINFLAMMATION["NEUROINFLAMMATION"] -->|"activates"| Als["Als"]
NEUROINFLAMMATION["NEUROINFLAMMATION"] -->|"activates"| Neuroinflammation_1["Neuroinflammation"]
NEUROINFLAMMATION["NEUROINFLAMMATION"] -->|"activates"| Inflammation_2["Inflammation"]
NEUROINFLAMMATION["NEUROINFLAMMATION"] -->|"activates"| Autophagy["Autophagy"]
CYTOKINES["CYTOKINES"] -->|"activates"| NEUROINFLAMMATION["NEUROINFLAMMATION"]
MITOCHONDRIAL_DYSFUNCTION["MITOCHONDRIAL DYSFUNCTION"] -->|"activates"| NEUROINFLAMMATION["NEUROINFLAMMATION"]
end
subgraph Pathology["Pathology"]
NEUROINFLAMMATION["NEUROINFLAMMATION"] -->|"associated with"| NEURON["NEURON"]
NEUROINFLAMMATION["NEUROINFLAMMATION"] -->|"associated with"| TAU["TAU"]
NEUROINFLAMMATION["NEUROINFLAMMATION"] -->|"associated with"| Neuroinflammation["Neuroinflammation"]
NEUROINFLAMMATION["NEUROINFLAMMATION"] -->|"associated with"| Inflammation["Inflammation"]
APOE["APOE"] -->|"associated with"| NEUROINFLAMMATION["NEUROINFLAMMATION"]
MICROGLIA["MICROGLIA"] -->|"associated with"| NEUROINFLAMMATION["NEUROINFLAMMATION"]
APP["APP"] -->|"associated with"| NEUROINFLAMMATION["NEUROINFLAMMATION"]
MITOCHONDRIA["MITOCHONDRIA"] -->|"associated with"| NEUROINFLAMMATION["NEUROINFLAMMATION"]
end
style NEUROINFLAMMATION fill:#5d4400,stroke:#4fc3f7,stroke-width:3px,color:#e0e0e0,font-weight:bold
style NEURODEGENERATION fill:#5d4400,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style NEURON fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style TAU fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style Neuroinflammation fill:#ef5350,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style Inflammation fill:#ef5350,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style Als fill:#ef5350,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style Neuroinflammation_1 fill:#ef5350,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style Inflammation_2 fill:#ef5350,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style Autophagy fill:#1b5e20,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style APOE fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style MICROGLIA fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style APP fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style MITOCHONDRIA fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style CYTOKINES fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style MITOCHONDRIAL_DYSFUNCTION fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0Outgoing (4186)
| Target | Relation | Type | Str |
|---|---|---|---|
| Oxidative Stress | therapeutic_target | pathway | 1.00 |
| Inflammasome | activates | pathway | 1.00 |
| Oxidative Stress | activates | pathway | 1.00 |
| DEMENTIA | associated_with | gene | 1.00 |
| Blood-Brain Barrier | therapeutic_target | pathway | 1.00 |
| Apoptosis | activates | pathway | 1.00 |
| neurodegeneration | causes | phenotype | 1.00 |
| Toll-Like Receptor | activates | pathway | 1.00 |
| Aging | associated_with | disease | 1.00 |
| Alzheimer | associated_with | disease | 1.00 |
| Amyotrophic Lateral Sclerosis | associated_with | disease | 1.00 |
| neurodegeneration | activates | process | 1.00 |
| OXIDATIVE STRESS | associated_with | gene | 1.00 |
| Parkinson | associated_with | disease | 1.00 |
| Blood-Brain Barrier | associated_with | pathway | 1.00 |
| MICROGLIA | associated_with | gene | 1.00 |
| Depression | activates | disease | 1.00 |
| Alzheimer | treats | disease | 1.00 |
| Neurodegeneration | activates | disease | 1.00 |
| MICROGLIA | causes | gene | 1.00 |
| Inflammation | associated_with | disease | 1.00 |
| Alzheimer | associated_with | disease | 1.00 |
| Infection | activates | disease | 1.00 |
| Als | therapeutic_target | disease | 1.00 |
| Pi3K/Akt | activates | pathway | 1.00 |
| Neurodegeneration | biomarker_for | disease | 1.00 |
| Neurodegeneration | biomarker_for | disease | 1.00 |
| Pi3K/Akt | activates | pathway | 1.00 |
| Neurodegeneration | causes | disease | 1.00 |
| MICROGLIA | therapeutic_target | gene | 1.00 |
| Als | treats | disease | 1.00 |
| Stroke | activates | disease | 1.00 |
| Neurodegeneration | causes | disease | 1.00 |
| Alzheimer | biomarker_for | disease | 1.00 |
| Alzheimer | treats | disease | 1.00 |
| Inflammation | regulates | disease | 1.00 |
| Parkinson | causes | disease | 1.00 |
| Inflammation | therapeutic_target | disease | 1.00 |
| Neuroinflammation | causes | disease | 1.00 |
| Inflammation | biomarker_for | disease | 1.00 |
| Alzheimer | causes | disease | 1.00 |
| Dementia | activates | disease | 1.00 |
| Neurodegeneration | activates | process | 1.00 |
| Als | biomarker_for | disease | 1.00 |
| Als | associated_with | disease | 1.00 |
| Als | associated_with | disease | 1.00 |
| Inflammation | causes | disease | 1.00 |
| Alzheimer | causes | disease | 1.00 |
| Dementia | therapeutic_target | disease | 1.00 |
| Blood-Brain Barrier | activates | pathway | 1.00 |
Incoming (6361)
| Source | Relation | Type | Str |
|---|---|---|---|
| entities-microglia-in-neurodegeneration | involved_in | wiki | 0.00 |
| entities-complement-system | involved_in | wiki | 0.00 |
| NEURODEGENERATION | biomarker_for | gene | 1.00 |
| APP/PS1 | activates | gene | 1.00 |
| CYTOKINES | therapeutic_target | gene | 1.00 |
| ALZHEIMER | biomarker_for | gene | 1.00 |
| ALZHEIMER | inhibits | gene | 1.00 |
| NF-ΚB | inhibits | gene | 1.00 |
| ALZHEIMER'S DISEASE | activates | gene | 1.00 |
| NEURODEGENERATIVE DISEASES | associated_with | gene | 1.00 |
| APP/PS1 | activates | gene | 1.00 |
| ASTROCYTES | therapeutic_target | gene | 1.00 |
| PARKINSON'S DISEASE | inhibits | gene | 1.00 |
| APOPTOSIS | associated_with | gene | 1.00 |
| DNA | therapeutic_target | gene | 1.00 |
| MICROGLIA | inhibits | gene | 1.00 |
| ALZHEIMER'S DISEASE | activates | gene | 1.00 |
| NEURODEGENERATIVE DISEASES | activates | gene | 1.00 |
| ALZHEIMER'S DISEASE | regulates | gene | 1.00 |
| NEURODEGENERATION | activates | gene | 1.00 |
| MICROGLIA | therapeutic_target | gene | 1.00 |
| PARKINSON'S DISEASE | therapeutic_target | gene | 1.00 |
| NEURODEGENERATION | activates | gene | 1.00 |
| NEURODEGENERATIVE DISEASES | activates | gene | 1.00 |
| ASTROCYTES | regulates | gene | 1.00 |
| GENES | regulates | gene | 1.00 |
| NEURODEGENERATION | therapeutic_target | gene | 1.00 |
| AMPK | activates | gene | 1.00 |
| CYTOKINES | therapeutic_target | gene | 1.00 |
| MICROGLIA | inhibits | gene | 1.00 |
| BRAIN INJURY | activates | gene | 1.00 |
| NF-ΚB | inhibits | gene | 1.00 |
| ALZHEIMER'S DISEASE | therapeutic_target | gene | 1.00 |
| ALZHEIMER'S DISEASE | regulates | gene | 1.00 |
| NEUROINFLAMMATION | inhibits | gene | 1.00 |
| TAU | therapeutic_target | gene | 1.00 |
| INFLAMMATION | inhibits | gene | 1.00 |
| PI3K | activates | gene | 1.00 |
| ASTROCYTES | activates | gene | 1.00 |
| PHAGOCYTOSIS | activates | gene | 1.00 |
| TAU | therapeutic_target | gene | 1.00 |
| ASTROCYTES | activates | gene | 1.00 |
| PHAGOCYTOSIS | activates | gene | 1.00 |
| INFLAMMATION | therapeutic_target | gene | 1.00 |
| TAU | associated_with | gene | 1.00 |
| NEURODEGENERATION | therapeutic_target | gene | 1.00 |
| MICROGLIA | regulates | gene | 1.00 |
| INFLAMMATION | inhibits | gene | 1.00 |
| NEUROINFLAMMATION | interacts_with | gene | 1.00 |
| ALZHEIMER | causes | gene | 1.00 |
Targeting Hypotheses (22)
Hypotheses where this entity is a therapeutic target
Mentioning Analyses (25)
Scientific analyses that reference this entity
What are the mechanisms by which microglial senescence contributes to ALS pathol
neurodegeneration | 2026-04-26 | 4 hypotheses Top: 0.776
Clinical Trial Landscaping for Alzheimer's Disease Therapeutics
neurodegeneration | 2026-04-16 | 0 hypotheses
How does Alectinib, a kinase inhibitor, achieve high-affinity binding to complem
neuroinflammation | 2026-04-16 | 5 hypotheses Top: 0.599
Blood-brain barrier tight junction disruption by neuroinflammatory cytokines
neurodegeneration | 2026-04-16 | 7 hypotheses Top: 0.919
What molecular mechanisms mediate SPP1-induced microglial phagocytic activation
neuroinflammation | 2026-04-15 | 7 hypotheses Top: 0.728
Experiments (2)
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| PGC-1α knockout analysis of PV+ interneuron maturation | validation | neurodevelopmental disorders | 0.850 | 0.00 | knockout mice | proposed | N/A |
| PV+ interneuron subtype diversification analysis | exploratory | neurodevelopmental disorders | 0.750 | 0.00 | mouse cortical PV+ interneuron | proposed | N/A |
Related Papers (20)
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| Small molecule-driven NLRP3 inflammation inhibition via interplay between ubiqui [PMID:30966861] | ["Han X", "Sun S", "Sun Y", "Song Q", "Z | Autophagy | 2020 | 1 |
| Enhancing TREM2 expression activates microglia and modestly mitigates tau pathol [PMID:40122810] | ["Chen Kai", "Li Fuyao", "Zhang Shuwen", | Journal of neuroinflammation | 2025 | 0 |
| Iron and the Intestinal Microbiome. [PMID:40603801] | Li H | Adv Exp Med Biol | 2025 | 0 |
| Renal denervation attenuates cardiac dysfunction in HFpEF by inhibiting the ATP- [PMID:40958035] | Li Z, Sun X, Wang Y | Basic Res Cardiol | 2025 | 0 |
| Enhancing TREM2 expression activates microglia and modestly mitigates tau pathol [PMID:40122810] | ["Chen Kai", "Li Fuyao", "Zhang Shuwen", | Journal of neuroinflammation | 2025 | 0 |
| Gastrodin regulates the TLR4/TRAF6/NF-κB pathway to reduce neuroinflammation and [PMID:38552431] | Wang W, Wang Y, Wang F, Xie G, Liu S, Li | Phytomedicine : international | 2024 | 0 |
| Joint-specific memory, resident memory T cells and the rolling window of opportu [PMID:38600215] | Chang MH, Fuhlbrigge RC, Nigrovic PA | Nat Rev Rheumatol | 2024 | 0 |
| Oral Microbiome: A Review of Its Impact on Oral and Systemic Health. [PMID:39338471] | Rajasekaran JJ, Krishnamurthy HK, Bosco | Microorganisms | 2024 | 0 |
| Gastrodin regulates the TLR4/TRAF6/NF-κB pathway to reduce neuroinflammation and [PMID:38552431] | Wang W, Wang Y, Wang F, Xie G, Liu S, Li | Phytomedicine : international | 2024 | 0 |
| Ferulic acid alleviates sciatica by inhibiting neuroinflammation and promoting n [PMID:36601662] | ["Zhang Di", "Jing Bei", "Chen Zhen-Ni", | CNS neuroscience & therapeutic | 2023 | 0 |
| Lomerizine inhibits LPS-mediated neuroinflammation and tau hyperphosphorylation [PMID:37435081] | Park, Hwang, Lee, Jang, Jeong et al. | Frontiers in immunology | 2023 | 0 |
| The role of the microbiota in glaucoma. [PMID:37866106] | Huang L, Hong Y, Fu X, Tan H, Chen Y, Wa | Molecular aspects of medicine | 2023 | 0 |
| Lomerizine inhibits LPS-mediated neuroinflammation and tau hyperphosphorylation [PMID:37435081] | Unknown | Frontiers in immunology | 2023 | 0 |
| Ferulic acid alleviates sciatica by inhibiting neuroinflammation and promoting n [PMID:36601662] | ["Zhang Di", "Jing Bei", "Chen Zhen-Ni", | CNS neuroscience & therapeutic | 2023 | 0 |
| Inhibition of autophagy in microglia and macrophages exacerbates innate immune r [PMID:36652438] | Hegdekar N, Sarkar C, Bustos S, Ritzel R | Autophagy | 2023 | 0 |
| The role of the microbiota in glaucoma. [PMID:37866106] | Huang L, Hong Y, Fu X, Tan H, Chen Y, Wa | Molecular aspects of medicine | 2023 | 0 |
| Inflammasome assembly in neurodegenerative diseases. [PMID:37633753] | Singh J, Habean ML, Panicker N | Trends in neurosciences | 2023 | 0 |
| The role of Toll-like receptors and neuroinflammation in Parkinson's disease. [PMID:35668422] | ["Heidari Arash", "Yazdanpanah Niloufar" | Journal of neuroinflammation | 2022 | 0 |
| Pyroptosis in acute pancreatitis and its therapeutic regulation. [PMID:35687256] | Al Mamun A, Suchi SA, Aziz MA | Apoptosis | 2022 | 0 |
| Microglia in multiple sclerosis: Protectors turn destroyers. [PMID:35882229] | Yong | Neuron | 2022 | 0 |
Debates (20)
Multi-agent debates referencing this entity
Hypothesis debate: SASP Modulation Rather Than Cell Elimination
closed · Rounds: 4 · Score: 0.00 · 2026-04-26
Hypothesis debate: Metabolic Reprogramming to Reverse Senescence
closed · Rounds: 4 · Score: 0.00 · 2026-04-26
Hypothesis debate: Metabolic Reprogramming to Reverse Senescence
closed · Rounds: 4 · Score: 0.00 · 2026-04-26
What are the mechanisms by which microglial senescence contributes to ALS pathol
active · Rounds: 6 · Score: 0.75 · 2026-04-26
Should PEA-PPARA endocannabinoid signaling be prioritized as a therapeutic strat
closed · Rounds: 4 · Score: 0.76 · 2026-04-23
Should metabolic reprogramming via SIRT1/NAD+/PGC-1alpha axis be prioritized to
closed · Rounds: 4 · Score: 0.81 · 2026-04-23
Analysis for knowledge gap 006 in the neurodegeneration domain.
closed · Rounds: 4 · Score: 0.79 · 2026-04-22
The astrocyte-mediated hypothesis proposes memory erasure but provides no molecu
closed · Rounds: 4 · Score: 0.65 · 2026-04-21
What is the current clinical trial landscape for AD therapeutics, and which mech
closed · Rounds: 4 · Score: 0.30 · 2026-04-21
Is the amyloid concentration in AD clinical trials rational given lecanemab's ap
closed · Rounds: 4 · Score: 0.70 · 2026-04-16
Related Research
Hypotheses and analyses mentioning NEUROINFLAMMATION in their description or question text
microglial inflammasome tone defines the therapeutic window for: How does gut mi
Score: 0.723 · neurodegeneration · 2026-04-26
The same signal may be beneficial early and damaging late. Testing microglial inflammasome tone with dietary fiber chall
Microglial Disease-Associated States: TREM2-Independent Pathways Driving Neuroin
Score: 0.710 · neurodegeneration · 2026-04-22
## Mechanistic Overview Microglial Disease-Associated States: TREM2-Independent Pathways Driving Neuroinflammation start
TLR4/MyD88/NF-κB Axis Blockade to Interrupt LPS-Mediated Gut-Brain Neuroinflamma
Score: 0.703 · neurodegeneration · 2026-04-16
**Molecular Mechanism and Rationale** The pathogenesis of Parkinson's disease (PD) involves complex interactions betwee
AQP4 Dysregulation Promotes Neuroinflammation Through Impaired CNS-Peripheral Im
Score: 0.680 · neurodegeneration · 2026-04-21
**Molecular Mechanism and Rationale** The molecular mechanism underlying AQP4-mediated neuroinflammation centers on the
NeuroD1-Mediated Astrocyte Reprogramming Attenuates Neuroinflammation Through Ep
Score: 0.650 · neurodegeneration · 2026-04-22
**Molecular Mechanism and Rationale** The molecular foundation of this therapeutic approach centers on the dual functio
GFAP-Bearing Circulating Extracellular Vesicles Originating from Reactive Astroc
Score: 0.640 · unknown disease · 2026-04-26
Reactive astrocytes release GFAP-positive extracellular vesicles (Astrocyte-EVs) into circulation with end-feet retracti
STING Antagonism Prevents Acute-to-Chronic Neuroinflammation Transition via Inte
Score: 0.601 · neuroinflammation · 2026-04-15
## Mechanistic Overview STING Antagonism Prevents Acute-to-Chronic Neuroinflammation Transition via Interruption of IFN-
Cardiovascular-Neuroinflammation Crosstalk Interruption
Score: 0.587 · Alzheimer's disease · 2026-04-04
# Cardiovascular-Neuroinflammation Crosstalk Interruption: Targeting Shared Inflammatory Mediators in Neurodegeneratio
Astrocyte cGAS/STING Activation Converts Protective into Destructive Neuroinflam
Score: 0.580 · neuroinflammation · 2026-04-21
## Mechanistic Overview Astrocyte cGAS/STING Activation Converts Protective into Destructive Neuroinflammation starts fr
Neuroinflammation-Driven TDP-43 Mislocalization via Microglial APOE4 Signaling
Score: 0.580 · neurodegeneration · 2026-04-21
**Molecular Mechanism and Rationale** The proposed mechanism centers on a complex inflammatory cascade initiated by APO
PINK1/PARK2-Mediated Mitophagy Enhancement for Neuroinflammation Control
Score: 0.571 · Neuroinflammation · 2026-04-20
**Molecular Mechanism and Rationale** The PINK1/PARK2 mitophagy pathway represents a critical quality control mechanism
BET Bromodomain Inhibition for Neuroinflammation Suppression
Score: 0.550 · neurodegeneration · 2026-04-25
BET Bromodomain Inhibition for Neuroinflammation Suppression
Lactate/Pyruvate Ratio Dynamics in CSF as a Neuroinflammation-Metabolism Interfa
Score: 0.532 · translational neuroscience · 2026-04-12
## Mechanistic Overview Lactate/Pyruvate Ratio Dynamics in CSF as a Neuroinflammation-Metabolism Interface Biomarker sta
Astrocyte-Specific DGAT1 Inhibition to Prevent Lipid Droplet-Induced Neuroinflam
Score: 0.515 · lipidomics · 2026-04-25
Astrocyte-Specific DGAT1 Inhibition to Prevent Lipid Droplet-Induced Neuroinflammation
Testosterone-Derived DHT Amplifies Microglial Androgen Receptor Signaling Drivin
Score: 0.490 · neuroinflammation · 2026-04-22
## Mechanistic Overview Testosterone-Derived DHT Amplifies Microglial Androgen Receptor Signaling Driving Male-Biased Ne